Abstract Tumour deposits (TDs) are established adverse prognostic features in colorectal carcinoma, yet their biologic significance and integration into current nodal staging systems remain controversial. Although TD burden has been associated with adverse prognosis beyond lymph node metastasis, its incremental staging relevance and the immune microenvironmental features of the primary tumour that may underlie the aggressive behaviour of TD-positive tumours remain incompletely defined.